PubMed:1967025 / 891-1061 JSONTXT

Annnotations TAB JSON ListView MergeView

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T29","span":{"begin":29,"end":45},"obj":"FMAID:82742"},{"id":"_T30","span":{"begin":29,"end":45},"obj":"FMAID:196731"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":170},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":170},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":170},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T5","span":{"begin":14,"end":25},"obj":"http://purl.obolibrary.org/obo/GO_0097503"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"T6","span":{"begin":130,"end":134},"obj":"http://purl.obolibrary.org/obo/UBERON_1000010"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T4","span":{"begin":63,"end":70},"obj":"http://edamontology.org/topic_3277"},{"id":"T5","span":{"begin":84,"end":89},"obj":"http://edamontology.org/topic_3678"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T6","span":{"begin":102,"end":108},"obj":"http://edamontology.org/operation_3435"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T4","span":{"begin":130,"end":134},"obj":"http://purl.obolibrary.org/obo/UBERON_1000010"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    HP-phenotype

    {"project":"HP-phenotype","denotations":[{"id":"T4","span":{"begin":130,"end":134},"obj":"Phenotype"},{"id":"T5","span":{"begin":150,"end":165},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0003764"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0100768"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":121,"end":134},"obj":"Disease"},{"id":"T4","span":{"begin":150,"end":165},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0020549"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005207"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":130,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_1000010"}],"text":"The extent of sialylation of oligosaccharides in the three hCG samples used in this study were 88% in normal hCG, 82% in invasive mole hCG and 63% in choriocarcinoma hCG."}